Wolverine Trading
PGEN icon

Wolverine Trading’s Precigen PGEN Stock Holding History

Wolverine Trading’s Portfolio PGEN Stock Details PGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-47,500
Closed -$67.5K – 6028
2025
Q2 		$67.5K Buy
47,500
+16,100
+51% +$22.9K ﹤0.01% 4271
2025
Q1 		$49.9K Buy
31,400
+12,200
+64% +$19.2K ﹤0.01% 4426
2024
Q4 		$17.9K Hold
19,200
– – ﹤0.01% 5119
2024
Q3 		$18.2K Buy
+19,200
New +$24.2K ﹤0.01% 4650
2024
Q2 		– Sell
-20,400
Closed -$29.6K – 5048
2024
Q1 		$29.6K Buy
+20,400
New +$29.3K ﹤0.01% 4302
2023
Q4 		– Sell
-10,900
Closed -$15.5K – 5022
2023
Q3 		$15.5K Sell
10,900
-8,300
-43% -$11.8K ﹤0.01% 4346
2023
Q2 		$20.2K Buy
19,200
+3,500
+22% +$4.13K ﹤0.01% 4100
2023
Q1 		$16K Buy
+15,700
New +$22.6K ﹤0.01% 4034
2022
Q4 		– Sell
-26,900
Closed -$55K – 4789
2022
Q3 		$55K Buy
26,900
+13,000
+94% +$27.4K ﹤0.01% 4115
2022
Q2 		$19K Buy
+13,900
New +$20.6K ﹤0.01% 4245
2022
Q1 		– Sell
-20,700
Closed -$79K – 6191
2021
Q4 		$79K Buy
20,700
+4,200
+25% +$18.1K ﹤0.01% 5182
2021
Q3 		$84K Buy
16,500
+5,900
+56% +$34K ﹤0.01% 5859
2021
Q2 		$69K Sell
10,600
-16,800
-61% -$117K ﹤0.01% 5539
2021
Q1 		$185K Sell
27,400
-26,400
-49% -$223K ﹤0.01% 5107
2020
Q4 		$535K Buy
53,800
+12,100
+29% +$78.4K ﹤0.01% 3092
2020
Q3 		$148K Sell
41,700
-8,900
-18% -$42.2K ﹤0.01% 3986
2020
Q2 		$247K Buy
+50,600
New +$172K ﹤0.01% 3563
2020
Q1 		– Sell
-95,800
Closed -$527K – 5093
2019
Q4 		$527K Buy
95,800
+6,900
+8% +$38.8K ﹤0.01% 3024
2019
Q3 		$491K Buy
+88,900
New +$604K ﹤0.01% 2647
2019
Q2 		– Sell
-78,900
Closed -$415K – 4961
2019
Q1 		$415K Buy
+78,900
New +$547K ﹤0.01% 2985

Other funds holding PGEN

PCM
Patient Capital Management Baltimore, Maryland $2.74B AUM 43.59% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
OCM
Occam Crest Management Darien, Connecticut $165M AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Wolverine Trading's PGEN Position: Q3 2025 in Review

Wolverine Trading sold out of Precigen (PGEN) in Q3 2025, closing a stake of 27,272 shares — an estimated $38.7K sold.

Wolverine Trading first reported a position in PGEN in Q3 2019 and held it in 12 quarters. The position peaked at $128K in Q4 2021. 167 funds tracked by Wall St. Rank hold PGEN as of Q3 2025.

  • Wolverine Trading reported no remaining Precigen position as of Q3 2025 after selling out during the quarter.
  • Wolverine Trading sold 27,272 Precigen shares in Q3 2025, an estimated $38.7K.
  • Wolverine Trading first reported a position in Precigen in Q3 2019 and held it in 12 quarters.
  • Wolverine Trading's Precigen position peaked at $128K in Q4 2021.
  • 167 funds tracked by Wall St. Rank held Precigen as of Q3 2025.

Based on Wolverine Trading's 13F filing for Q3 2025, filed 14 Nov 2025.